[This corrects the article DOI: 10.3389/fendo.2023.1149328.].
Keywords: Dulaglutide; Liraglutide; Semaglutide; gastrointestinal adverse effects; glucagon-like peptide-1 receptor agonist; intolerance; network meta-analysis.
Copyright © 2023 Zhang, Zhang, Tan, Chen, Zhou, Liu and Yu.